NCT06172855
Recruiting
Not Applicable
The Study on the Effectiveness and Safety of Electroacupuncture at ST36 (Zusanli) in Treating Primary Premature Ejaculation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 site in 1 country35 target enrollmentJanuary 1, 2024
ConditionsPremature Ejaculation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Premature Ejaculation
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Enrollment
- 35
- Locations
- 1
- Primary Endpoint
- Change from baseline intravaginal ejaculatory latency time
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
A pilot prospective single-arm cohort study on the Effectiveness and Safety of Electroacupuncture at ST36(Zusanli) in Treating Primary Premature Ejaculation
Detailed Description
This is a pilot prospective single-arm cohort study to verify the Effectiveness and Safety of Electroacupuncture at ST36(Zusanli) in Treating Primary Premature Ejaculation, based on the result on animal study that daily electroacupuncture at ST36(Zusanli) for 30 days could delay the ejaculation of male SD rats.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18 to 60
- •Heterosexual, with a single, stable partner for more than 6 months
- •Symptoms of primary premature ejaculation: Complaints of IELT ≤ 1 min since the first sexual intercourse, and poor ability to control ejaculation leading to anxiety, annoyance, depression or/and avoidance of sexual life and other negative effects.
Exclusion Criteria
- •Urinary system infection: Urinary tract infection symptoms (such as urinary tract irritation symptoms, prostatitis symptoms, blood semen, etc.) or urine routine shows abnormal white blood cells and red blood cells
- •Abnormal androgen: sex hormone examination shows abnormal androgen (testosterone)
- •Systemic diseases: ask about medical history of hypertension, diabetes, alcohol dependence, coronary heart disease and mental disorders
- •Organic abnormalities: Abnormal development of external genitalia, bilateral testes, epididymis and spermatic cords with obvious abnormalities on palpation
- •History of surgery and trauma: Dorsal nerve block of the penis, erectile function-related surgery, prostate surgery, pelvic surgery, etc.
- •Influence of drugs: within one month before enrollment, have taken SSRI, tramadol and other drugs to treat diseases
- •Allergy to dapoxetine and lidocaine
- •History of drug, alcohol or substance abuse in the past 6 months
- •Accompanied by erectile dysfunction: International Index of Erectile Function-5 (International Index of Erectile Function, IIEF-5) score ≤ 21 points
Outcomes
Primary Outcomes
Change from baseline intravaginal ejaculatory latency time
Time Frame: Week 6, 10, 14, 18
IELT
Secondary Outcomes
- Premature Ejaculation Diagnose Tool(Week 0, 6, 10, 14, 18)
- Penile Nerve Electrophysiology(Week 0, 6, 18)
- fMRI(Week 0, 6)
- Premature Ejaculation Profile(Week 0, 6, 10, 14, 18)
- Chinese Index of Premature Ejaculation(Week 0, 6, 10, 14, 18)
- Clinical Global Impression of Change(Week 6, 18)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Effectiveness and Safety of Electroacupuncture on Poststroke Urinary IncontinenceUrinary IncontinenceStroke, ComplicationNCT02819336Kyunghee University56
Recruiting
Not Applicable
Efficacy and Safety of Electroacupuncture for ICU Sepsis PatientsSepsisNCT06666946Shusheng Li308
Completed
Phase 2
Efficacy and Safety Study of Electroacupuncture for Simple Female Stress Urinary incontinence-a Multicenter TrialUrinary Stress IncontinenceNCT01784172Guang'anmen Hospital of China Academy of Chinese Medical Sciences504
Completed
Not Applicable
Electroacupuncture for Poststroke Patients With Shoulder PainStrokeShoulder PainStroke, ComplicationCerebral InfarctionCerebral HemorrhageNCT03086863Kyunghee University45
Unknown
Not Applicable
The Exploratory Study of Electroacupuncture in the Treatment of Peripheral Neuropathy Induced by Platinum Based Chemotherapy DrugsChemotherapy-induced Peripheral NeuropathyNCT03048591Tianjin Medical University Cancer Institute and Hospital72